Please login to the form below

Not currently logged in
Email:
Password:

Roche's Chugai recalls Vesanoid in Japan

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

Roche's Japanese subsidiary Chugai has recalled its Vesanoid capsules for acute promyelocytic leukemia in Japan.

The recall follows the discovery of bovine-derived material sourced from Canada in a specific batch of the capsules imported from Roche, which is based in Switzerland.

Use of such material requires a partial amendment to the approval document for use in Japan.

Chugai and Roche had agreed not to export Vesanoid capsules using the material to Japan, but went ahead with the exportation anyway because Roche believed that its use was approved in the region.

Vesanoid had annual sales of approximately USD 24m for the twelve months ended April 2007, based on IMS sales data.

3rd August 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics